Evidence map›Paper›PMID 41628219›Full record

ArticlePloS one2026

Regulation of tension-dependent localization of LATS1 and LATS2 to adherens junctions.

Chamika De Silva, Brian A Kelch, Dannel McCollum

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Chamika De SilvaDepartment of Biochemistry & Molecular Biotechnology, UMass Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-3846-4313
Brian A KelchDepartment of Biochemistry & Molecular Biotechnology, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Dannel McCollumDepartment of Biochemistry & Molecular Biotechnology, UMass Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-0278-2715

Funding

Regulation of Hippo pathway signaling by mechanical forcesR01GM058406 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCCOLLUM, DANNEL · 1998 to 2023
$8.5M
NIGMS NIH HHS R01 GM058406
6 · The paper itself

Abstract

The LIM domain protein LIMD1 is a critical regulator of the Hippo signaling pathway, acting to sequester the kinases LATS1/2 to adherens junctions (AJs) in response to mechanical strain. Here, we identify the molecular basis for LIMD1 binding and recruitment of LATS1/2 to AJs. We show that while the LIM domains of LIMD1 are sufficient for AJ localization and binding to LATS1/2, recruitment of LATS1 to AJ requires both the intrinsically disordered region (IDR) in the N-terminus as well as the LIM domains. We further dissected the LIM domains and found that LIM1 and LIM2, but not LIM3, are necessary for LATS1 AJ localization. Point mutations that disrupt strain sensitivity in either the first or second LIM domain disrupt both binding and recruitment of LATS1/2 to AJs. Mechanistically, LIMD1 binds LATS1/2 through a conserved linear motif, the LATS-LATCH, which we identified by AlphaFold modeling and confirmed by biochemical and localization assays. The LATS-LATCH is required for mechanical strain-dependent recruitment of LATS1 and LATS2 to AJs. Further analysis of the LATS2-LATCH showed that it is sufficient for binding to LIMD1 and localization to AJs. Mutation of predicted contact residues within the LATS2-LATCH both disrupts its binding to LIMD1 and localization to AJs. These findings define a bipartite mechanism for LIMD1-dependent recruitment of LATS1/2 involving LIM domain-LATCH interactions and N-terminal IDR functions, providing insight into how mechanical signals are transduced through the Hippo pathway.

Indexed as

Adherens JunctionsProtein Serine-Threonine KinasesTumor Suppressor ProteinsAnimalsHumansLIM Domain ProteinsProtein BindingProtein DomainsSignal TransductionLATS1 protein, humanLATS2 protein, humanLIM Domain ProteinsProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID41628219
PMCPMC12863670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.